Related Experiment Videos

Inactivated suckling mouse brain rabies vaccine provides short-term immunity in capuchin monkeys (Cebus apella)

E C Passos1, P M Germano, M A Guimarães

  • 1Instituto Pasteur, Av. Paulista, 393, São Paulo, SP, Brazil 01311-000.

Insights

This study shows that inactivated suckling mouse brain vaccine (SMBV) induced a rabies immune response in capuchin monkeys. However, the neutralizing antibody titers were short-lived, indicating limited long-term protection.

Area of Science:

  • Veterinary Immunology
  • Virology
  • Primate Research

Background:

  • Rabies remains a significant public health concern, necessitating effective vaccination strategies in various animal populations.
  • Capuchin monkeys (Cebus apella) are relevant models for studying vaccine efficacy due to their physiological similarities to humans.

Purpose of the Study:

  • To evaluate the immunogenicity and duration of the immune response to an inactivated suckling mouse brain vaccine (SMBV) against rabies in capuchin monkeys.

Main Methods:

  • Eight capuchin monkeys received three intramuscular injections of 1-ml doses of 2% SMBV suspension at 0, 30, and 60 days.
  • Serum samples were collected serially over 365 days and analyzed for rabies-neutralizing antibodies using a simplified fluorescence inhibition assay.

Main Results:

  • All vaccinated capuchin monkeys developed neutralizing antibodies with titers exceeding 0.5 IU/ml post-vaccination.
  • The induced immune response, measured by antibody titers, persisted for a mean duration of 122.3 +/- 32.6 days.

Conclusions:

  • The inactivated suckling mouse brain vaccine (SMBV) is capable of eliciting an immune response in capuchin monkeys.
  • The duration of protection conferred by this SMBV in capuchin monkeys is limited, suggesting a need for further investigation into vaccine strategies for sustained immunity.

Related Concept Videos